Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Feb;49(2):120-125.
doi: 10.1097/SHK.0000000000000958.

Lactate and Immunosuppression in Sepsis

Affiliations
Review

Lactate and Immunosuppression in Sepsis

Benjamin Nolt et al. Shock. 2018 Feb.

Abstract

Serum lactate levels are traditionally interpreted as a marker of tissue hypoxia and often used clinically as an indicator of severity and outcome of sepsis/septic shock. Interestingly, recent studies involving the effects of tumor-derived lactate suggest that lactate itself may have an immunosuppressive effect in its local environment. This finding adds to the recent advances in immunometabolism that shed light on the importance of metabolism and metabolic intermediates in the regulation of innate immune and inflammatory responses in sepsis. In this article, we summarize recent studies, showing that the activation of immune cells requires aerobic glycolytic metabolism and that lactate produced by aerobic glycolysis may play an immunosuppressive role in sepsis.

PubMed Disclaimer

Conflict of interest statement

The authors report no conflicts of interest.

Figures

Fig. 1
Fig. 1
Possible mechanisms by which lactate can induce the macrophage transition to an anti-inflammatory phenotype.
Fig. 2
Fig. 2
Potential role of increased lactate in the regulation of immune cell function.

Similar articles

Cited by

References

    1. Angus DC, van der Poll T. Severe sepsis and septic shock. N Engl J Med 2013; 369:840–851. - PubMed
    1. Mira JC, Gentile LF, Mathias BJ, Efron PA, Brakenridge SC, Mohr AM, Moore FA, Moldawer LL. Sepsis pathophysiology, chronic critical illness, and persistent inflammation-immunosuppression and catabolism syndrome. Crit Care Med 2017; 45:253–262. - PMC - PubMed
    1. Delano MJ, Ward PA. The immune system's role in sepsis progression, resolution, and long-term outcome. Immunol Rev 2016; 274:330–353. - PMC - PubMed
    1. Kakihana Y, Ito T, Nakahara M, Yamaguchi K, Yasuda T. Sepsis-induced myocardial dysfunction: pathophysiology and management. J Intensive Care 2016; 4:22. - PMC - PubMed
    1. Angus DC. The search for effective therapy for sepsis: back to the drawing board? JAMA 2011; 306:2614–2615. - PubMed

Publication types